To assess the role of MSCs modified by IL10 on mice with tumors in vivo, we established a subcutaneous mice model with pancreatic cancer, MSC-IL10 was injected into the tail vein once and the effect on tumor growth on mice was evaluated. Here, IL10 is linked to pancreatic neoplasm.